Hasan, K. M.; Elmeshhadany, A. Y.; Shabila, N. P. Evaluation of Ruxolitinib Versus Best Available Therapy in Treating Primary Myelofibrosis. Sultan Qaboos Univ Med J 2022, 22, 393-399.